SEC Form 4 · accession 0001144204-15-012338
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher P Leamon
Officer — Vice President of Research
Period of report
Feb 10, 2015
Accepted (ET)
Feb 26, 2015 · 6:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 10, 2015 | M | 13,089 | $1.91 | A | 39,855 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.91 | Feb 10, 2015 | M | 13,089 | A | — | Feb 10, 2015 | Common Stock | 13,089 | 0 | D |
Explanation of responses
- F1The option is fully vested and immediately exercisable.